title: [Drug treatment of chronic ventricular arrhythmia].
abstract: The treatment of chronic ventricular arrhythmias depends on the severity and tolerance of the arrhythmia. Extrasystoles, even repetitive, in the healthy heart, are usually respected when asymptomatic or treated with betablockers in first intention when symptomatic. These drugs should also be proposed for patients with ischemic heart disease and non-sustained ventricular tachycardia, a situation in which Class I antiarrhythmics should be avoided. The prevention of sustained ventricular tachycardial may be empirical, with betablockers and/or amiodarone, or guided by the results of pharmacological tests during endocavitary electrophysiological studies.
authors.affiliation: Hôpital Antoine-Béclère, Clamart.
authors.forename: G
authors.initials: G
authors.lastname: Motté
authors.forename: M
authors.initials: M
authors.lastname: Slama
authors.forename: S
authors.initials: S
authors.lastname: Dinanian
authors.forename: C
authors.initials: C
authors.lastname: Sebag
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000503:physiopathology; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002304:Cardiac Pacing, Artificial; D002908:Chronic Disease; D003663:Decision Trees; D006352:Heart Ventricles; D006801:Humans; D017202:Myocardial Ischemia / Q000503:physiopathology; D017180:Tachycardia, Ventricular / Q000188:drug therapy*; D016277:Ventricular Function, Left
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents
vernacular_title: Traitement médicamenteux des arythmies ventriculaires chroniques.